Average Co-Inventor Count = 6.19
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sage Therapeutics, Inc. (15 from 92 patents)
2. Merck Sharp + Dohme Corp. (11 from 2,405 patents)
3. Merck Sharp + Dohme B.v. (3 from 55 patents)
4. Sage Therpeutics, Inc. (1 from 1 patent)
27 patents:
1. 12201640 - 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof
2. 11945836 - Compositions and methods for treating CNS disorders
3. 11912737 - 19-nor neuroactive steroids and methods of use thereof
4. 11344563 - 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
5. 11261211 - 19-NOR neuroactive steroids and methods of use thereof
6. 11241446 - 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
7. 10822370 - 19-nor neuroactive steroids and methods of use thereof
8. 10774108 - Compositions and methods for treating CNS disorders
9. 10391106 - 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
10. 10377790 - 19-nor neuroactive steroids and methods of use thereof
11. 10342810 - 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
12. 10196354 - 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
13. 10172871 - 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
14. 10023606 - 19-nor neuroactive steroids and methods of use thereof
15. 9884043 - RORgammaT inhibitors